4.1 Article

Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria

Journal

HIV MEDICINE
Volume 13, Issue 9, Pages 526-532

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1468-1293.2012.01003.x

Keywords

albuminuria; HIV infection; proteinuria; urine albumin; creatinine ratio; urine protein; creatinine ratio

Funding

  1. Boehringer Ingelheim
  2. Bristol Myers Squib
  3. Gilead
  4. Merck Sharp and Dohme
  5. Tibotec
  6. Viiv Healthcare
  7. Bristol Myers Squibb
  8. Gilead Sciences
  9. Janssen-Cilag
  10. Abbott
  11. Janssen
  12. Merck

Ask authors/readers for more resources

Objective We recently showed that a urine albumin/total protein ratio (uAPR)??30?mg/mmol) into two groups: those with predominantly tubular proteinuria (TP) (uAPR??100?mg/mmol), a renal assessment was made; eight had a kidney biopsy. In all cases, the uAPR results correlated with the nephrological diagnosis. Conclusions In HIV-infected patients, measuring uAPR may help to identify patients in whom a renal biopsy is indicated, and those in whom tubular dysfunction might be an important cause of proteinuria and which may be related to antiretroviral toxicity. We suggest that this would be useful as a routine screening procedure in patients with proteinuria.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available